Author

Tarek Gensheimer

Boehringer Ingelheim (Germany)Primary ORCID profile (0009-0002-8232-8589 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Tarek GensheimeriD1 paper · University of Twente

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:scRNA-seq· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Agnieszka Wytyk· 1 shared Anastasia M. Funk· 1 shared Annalena Branz· 1 shared Christoph H. MayriD· 1 shared Danny David JonigkiD· 1 shared Irina ShalashovaiD· 1 shared Jan C. KampiD· 1 shared Jochen Drescher· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Agnieszka Wytyk

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Modeling Endothelial Dysfunction in Idiopathic Pulmonary Fibrosis: Bridging Mechanistic Insights and Translational Applications

Annalena Branz, Irina Shalashova, Anastasia M. Funk, Tarek Gensheimer, Agnieszka Wytyk, Susanne L. Wespel, Jochen Drescher, Christoph H. Mayr, Lavinia Neubert, Jan C. Kamp, Mark Kühnel, Danny David Jonigk, Manfred Frick, Muriel Lizé

This paper identifies PMVEC alterations in IPF using single-cell RNA sequencing and spatial transcriptomics, develops endothelial injury models, and validates functional assays for drug discovery.

bioRxiv · Sep 29, 2025 · PreprintCell Biology